CLINICAL STUDY. A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1 diabetes. The theory is that the drug could preserve the patient’s remaining insulin production. A large number of hospitals throughout Sweden are participating in this large project, which is funded by the Swedish Research Council within clinical treatment research. The…
Hope of more donor hearts suitable for transplantation
MULTICENTER STUDY. Improved Heart is the first prospective multicenter study in the world where evaluation of organ donors’ cardiac function is going to take place. The aim of the study is to include hearts with mild dysfunction to be acceptable for transplantation as well. In Sweden, hearts like this have been transplanted for several years with good results, but the status of this research has not been sufficient to change…
Overview ahead of VR’s announcements in spring 2023
GRANTS. The Research Support Office at Sahlgrenska Academy lists here news for The Swedish Research Council’s upcoming calls for proposals in medicine and health spring 2023. The Swedish Research Council will have an information meeting (via Zoom, in Swedish) about the call year 2023: https://www.vr.se/aktuellt/evenemang/evenemangsarkiv/2022-12-16-informationsmote-om-utlysningsaret-2023.html NEW! Consolidator grant within medicine and health. Announced every year from 2023 and onwards. The purpose of the grant is to give the most prominent…
Metformin treatment seems to prolong pregnancy in preterm preeclampsia
CLINICAL TREATMENT RESEARCH. Lina Bergman, senior obstetrician at Sahlgrenska University Hospital and associate professor at Sahlgrenska Academy’s Institute of Clinical Sciences, has been awarded over SEK 19 million for a Swedish Research Council project in clinical therapy research on preeclampsia. Preeclampsia is one of the most common causes of preterm birth, since delivery of the placenta cures the disorder. Bergman’s research involves using the pharmaceutical drug metformin (or a placebo)…
Arvid Carlsson’s drug candidate tried for treatment-resistant depression
GRANT. SSRI drugs are often effective against depression, but they fail to help around one-third of patients. An extensive clinical trial is now beginning in which ongoing treatment with an SSRI will be supplemented with a drug candidate developed by Nobel Laureate Arvid Carlsson before his death. The clinical trial is being led by Elias Eriksson, professor of pharmacology, who is also an old colleague and friend of Arvid Carlsson.…